Therapy of Non-Dermatophytic Mycoses in Animals
Overview
Authors
Affiliations
This review focuses on aspects of antimycotic therapy specific to veterinary medicine. In the first part, drug availability, limited mostly by economic consideration but also by clinical applicability and specific adverse effects, is described for polyenes, 5 fluorocytosine, azoles, echinocandins and terbinafine. In the second part, current knowledge and experience in the treatment of selected fungal infections are overviewed. These mycoses include disseminated mold infections in small animals (dogs and cats) and avian species, upper respiratory tract infections of small animals (sino-nasal and sino-orbital aspergillosis) and horses (guttural pouch mycosis), eumycetoma, infections caused by dimorphic fungi, (blastomycosis, histoplasmosis, coccidioidomycosis, paracoccidioidomycosis and sporothrichosis) and by yeasts and yeast-like microorganism ( spp. and ).
Canizares-Cooz D, Garcia-Parraga D, Rubio-Langre S, Encinas T, Moron-Elorza P Vet Sci. 2025; 12(1).
PMID: 39852892 PMC: 11769232. DOI: 10.3390/vetsci12010017.
Grecu M, Minea B, Foia L, Bostanaru-Iliescu A, Miron L, Nastasa V Molecules. 2023; 28(14).
PMID: 37513437 PMC: 10383344. DOI: 10.3390/molecules28145565.
Vercelli C, Peano A, Piovano G, Corona A, Gambino G, Re G Med Mycol Case Rep. 2021; 32:61-63.
PMID: 33912382 PMC: 8066322. DOI: 10.1016/j.mmcr.2021.04.001.
Special Issue: Treatments for Fungal Infections.
Segal E, Elad D J Fungi (Basel). 2018; 4(4).
PMID: 30545148 PMC: 6308925. DOI: 10.3390/jof4040135.